Bristol-Myers Squibb (BMY) option prices bid into quarter results
Bristol-Myers Squibb (NYSE: BMY) February weekly 65 straddle priced for a move of +/- 3% into the expected release of quarter results before the bell on February 4.
Bristol-Myers Squibb (NYSE: BMY) February weekly 65 straddle priced for a move of +/- 3% into the expected release of quarter results before the bell on February 4.